The latest news from Sutura

Stay up-to-date with Sutura Therapeutics' latest innovations and advancements by visiting our newsroom regularly.

Edwin Wagena 12/04/2024 Edwin Wagena 12/04/2024

Sutura Therapeutics at BioTrinity 2024

Join our CEO, Edwin Wagena, at BioTrinity 2024 to explore the future of biotech and discover more about our cutting-edge drug conjugate platform.

Edwin Wagena 05/09/2023 Edwin Wagena 05/09/2023

PeptiGos, a Next Generation CPP Platform

After 40 years, cell-penetrating peptides are finally realising their potential - Dr Wouter Eilers of Sutura explains how Sutura’s PeptiGo platform aims to perfect delivery.

Edwin Wagena 24/05/2023 Edwin Wagena 24/05/2023

Sutura Therapeutics Completes Investment Round

BREAKING: Sutura Therapeutics, a private biopharmaceutical company developing peptide-based biomolecular medicinal products, completes seed investment round.